We are live on ! Find out more
AI

Acuitas Investments Portfolio holdings

AUM $1.43M
1-Year Est. Return 17.52%
This Fund
S&P 500
This Quarter Est. Return
+19.01%
1 Year Est. Return
+17.52%
3 Year Est. Return
+145.17%
5 Year Est. Return
+267.61%
10 Year Est. Return
AUM
$192M
AUM Growth
+$21.4M
Cap. Flow
+$9.25M
Cap. Flow %
4.83%
Top 10 Hldgs %
22.29%
Holding
131
New
16
Increased
54
Reduced
31
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 16.32%
2 Industrials 15.45%
3 Consumer Discretionary 13.01%
4 Technology 12.67%
5 Materials 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIL icon
76
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
$889K 0.46%
9,732
-4,239
-30% -$388K
VLRS
77
Controladora Vuela Compania de Aviacion
VLRS
$939M
$856K 0.45%
91,300
+57,900
+173% +$422K
KVHI icon
78
KVH Industries
KVHI
$157M
$836K 0.44%
158,968
+30,255
+24% +$148K
IVVD icon
79
Invivyd
IVVD
$218M
$822K 0.43%
208,640
+61
+0% +$115
SPRB
80
Spruce Biosciences
SPRB
$129M
$806K 0.42%
3,668
+1
+0% +$116
GIFI
81
DELISTED
Gulf Island Fabrication
GIFI
$795K 0.42%
209,851
+1,347
+0.6% +$5.44K
FONR
82
DELISTED
Fonar
FONR
$761K 0.4%
+218,646
New +$3.64M
CSTE icon
83
Caesarstone
CSTE
$79.5M
$747K 0.39%
+162,647
New +$656K
ASTC icon
84
Astrotech Corp
ASTC
$17.8M
$739K 0.39%
62,570
+9,623
+18% +$83K
KOD icon
85
Kodiak Sciences
KOD
$2.84B
$712K 0.37%
234,092
+87,043
+59% +$194K
IVAC
86
DELISTED
Intevac Inc
IVAC
$710K 0.37%
+164,268
New +$612K
KNTE
87
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$687K 0.36%
+289,766
New +$513K
AXR icon
88
AMREP Corp
AXR
$119M
$681K 0.36%
96,090
+65,184
+211% +$1.16M
NUVB icon
89
Nuvation Bio
NUVB
$2.32B
$661K 0.34%
460,471
+143,972
+45% +$185K
LENZ
90
LENZ Therapeutics
LENZ
$168M
$621K 0.32%
27,797
-169
-0.6% -$2.79K
AVIR icon
91
Atea Pharmaceuticals
AVIR
$420M
$615K 0.32%
171,098
+47,671
+39% +$144K
NTGR icon
92
NETGEAR
NTGR
$635M
$611K 0.32%
+41,884
New +$542K
EGAN icon
93
eGain
EGAN
$201M
$562K 0.29%
+67,524
New +$475K
RAIN
94
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$539K 0.28%
410,464
+1,208
+0.3% +$1.3K
NKTR icon
95
Nektar Therapeutics
NKTR
$2.58B
$515K 0.27%
60,747
+12,650
+26% +$95.8K
BOLT icon
96
Bolt Biotherapeutics
BOLT
$7.78M
$515K 0.27%
22,973
-46
-0.2% -$895
NXTC icon
97
NextCure
NXTC
$26.7M
$492K 0.26%
31,067
+7,166
+30% +$104K
RFL icon
98
Rafael Holdings
RFL
$107M
$487K 0.25%
326,885
+90,185
+38% +$159K
CUTR
99
DELISTED
Cutera, Inc.
CUTR
$478K 0.25%
135,700
TATT icon
100
TAT Technologies
TATT
$515M
$472K 0.25%
46,480
+58
+0.1% +$516

Similar funds

Acuitas Investments's Q4 2023 Portfolio in Review

As of Q4 2023, Acuitas Investments held 131 positions worth $192M, up 13% from $170M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Acuitas Investments deployed $9.25M of net new capital in Q4 2023, opening 16 new positions and adding to 54 existing holdings. Its largest new stake was Fonar: 218,646 shares worth $761K.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Solaris Energy Infrastructure, an estimated $2.63M trimmed.

  • Acuitas Investments's largest Q4 2023 buy was Fonar: 218,646 shares worth $761K.
  • Acuitas Investments added most to Seneca Foods Class A in Q4 2023, an estimated $3.28M increase.
  • Acuitas Investments's biggest Q4 2023 reduction was Solaris Energy Infrastructure, cutting an estimated $2.63M.
  • Acuitas Investments fully exited Oportun Financial in Q4 2023, selling an estimated $2.08M.
  • Acuitas Investments's ten largest holdings make up 22% of its $192M portfolio in Q4 2023.
  • Acuitas Investments opened 16 new positions and closed 14 in Q4 2023.
  • Acuitas Investments's portfolio value rose 13% quarter-over-quarter to $192M.

Based on Acuitas Investments's 13F filing for Q4 2023, filed 2 Feb 2024.